< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Other clinical sciences not elsewhere classified
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 79
- Personalized precision medicine for the prevention and reversal of type 1 diabetes: a stepwise approachFrom1 Oct 2024 → TodayFunding: BOF - projects
- Neutrophils and their role in type 1 diabetesFrom10 Sep 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Continuous glucose monitoring for women with gestational diabetes: a randomized controlled trial: the CORDELIA studyFrom1 Jan 2024 → 29 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionFrom1 Nov 2023 → TodayFunding: HORIZON.2.4 - Digital, Industry and Space
- Quality of diabetes care: the role of health dataFrom29 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuationFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Innovative strategies for screening, diagnosis and prevention of type 1 diabetes.From13 Dec 2022 → 15 Dec 2022Funding: BOF - various
- European pre-T1D RegistryFrom1 Dec 2022 → TodayFunding: Foreign private sponsor - undefined
Publications
1 - 10 of 633
- Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONE(2024)
Authors: Chantal Mathieu, Pieter Gillard
- Knowledge and prescribing behaviour of Flemish general practitioners regarding novel glucose-lowering medications: Online cross-sectional survey(2024)
Authors: Pavlos Mamouris, Chantal Mathieu, Geert Goderis
Pages: 441 - 447 - Review Article - Diabetes Technology in the Hospital: An Update(2024)
Authors: Roman Vangoitsenhoven, Pieter Gillard, Chantal Mathieu
Pages: 173 - 182 - Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 587 - 595 - Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.(2024)
Authors: Chantal Mathieu
Pages: 1276 - 1298 - The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study(2024)
Authors: Jolien De Meulemeester, Chantal Mathieu, Pieter Gillard
- The role of incretin receptor agonists in the treatment of obesity(2024)
Authors: Chantal Mathieu
- 2024: The year to take European action on diabetes to the next level(2024)
Authors: Chantal Mathieu
Pages: 1155 - 1158 - Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review(2024)
Authors: Chantal Mathieu
- Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study(2024)
Authors: Steffen Fieuws, Chantal Mathieu, Pieter Gillard
Pages: 488 - 493
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)